Herbas VPB

Print
EN | LT
LT - METHODS FOR ASSESSING HOMOLOGOUS RECOMBINATION DEFICIENCY AND PREDICTING RESPONSE TO CANCER TREATMENT
EN - METHODS FOR ASSESSING HOMOLOGOUS RECOMBINATION DEFICIENCY AND PREDICTING RESPONSE TO CANCER TREATMENT

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C12Q 1/6886
European patent
(11) Number of the document 2981624
(13) Kind of document T
(96) European patent application number 14779403.6
Date of filing the European patent application 2014-04-04
(97) Date of publication of the European application 2016-02-10
(45) Date of publication and mention of the grant of the patent 2019-12-18
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2014/033014
Date 2014-04-04
PCT application publication
(87) Number WO 2014/165785
Date 2014-10-09
Priority applications
(30) Number Date Country code
201361809105 P 2013-04-05 US
201361913762 P 2013-12-09 US
Inventors
(72)
ABKEVICH, Victor, US
TIMMS, Kirsten, US
GUTIN, Alexander, US
Grantee
(73) Myriad Genetics, Inc., 320 Wakara Way, Salt Lake City, UT 84108, US
Title
(54) METHODS FOR ASSESSING HOMOLOGOUS RECOMBINATION DEFICIENCY AND PREDICTING RESPONSE TO CANCER TREATMENT
  METHODS FOR ASSESSING HOMOLOGOUS RECOMBINATION DEFICIENCY AND PREDICTING RESPONSE TO CANCER TREATMENT
Last update date 2021-04-30